DOTS is the WHO-recommended strategy for tuberculosis detection and treatment. It involves identifying infectious TB patients through microscopy, observing patients swallowing anti-TB drugs daily for 6-8 months, and regularly monitoring patients' progress. DOTS was launched in Pakistan in 1995 but faced challenges until being expanded nationwide by 2005. While cure rates and coverage increased under DOTS, Pakistan still faces ongoing issues with drug-resistant TB, capacity, and monitoring systems. The updated Stop TB Strategy aims to further improve TB control globally through universal access to diagnosis and treatment.
National Leprosy Eradication Programme (NLEP)Kavya .
Chronic infectious disease caused by Mycobacterium leprae.
It usually affects the skin and peripheral nerves
Long incubation period generally 5-7 years.
Classified as paucibacillary or multibacillary
permanent disability
Timely diagnosis and treatment of cases
Pulse Polio is an immunisation campaign established by the government of India to eliminate poliomyelitis (polio) in India by vaccinating all children under the age of five years against the polio virus.
This ppt contains all the information about Revised NationalTuberculosis Control programme (RNTCP) It is useful for students of the medical field learning Preventive and social medicine, Swasthavritta (Ayurved) and everyone who is interested in in knowing about it.
National Leprosy Eradication Programme (NLEP)Kavya .
Chronic infectious disease caused by Mycobacterium leprae.
It usually affects the skin and peripheral nerves
Long incubation period generally 5-7 years.
Classified as paucibacillary or multibacillary
permanent disability
Timely diagnosis and treatment of cases
Pulse Polio is an immunisation campaign established by the government of India to eliminate poliomyelitis (polio) in India by vaccinating all children under the age of five years against the polio virus.
This ppt contains all the information about Revised NationalTuberculosis Control programme (RNTCP) It is useful for students of the medical field learning Preventive and social medicine, Swasthavritta (Ayurved) and everyone who is interested in in knowing about it.
Polio is a viral disease that destroys the nerve cells present in the spinal cord causing paralysis or muscle weakness to some part of the body.
Pulse Polio Programme was launched in 1995 after a resolution for a global initiative of polio eradication was adopted by World Health Assembly (WHA) in 1988.
On 19 November 1985, GOI renamed EPI program, modifying the schedule as ‘Universal Immunization Program’ dedicated to the memory of Late Prime Minister Mrs Indira Gandhi.
UIP has two vital components: immunization of pregnant women against tetanus, and immunization of children
Universal Immunization Programme (UIP), started in India in 1985.
Ministry of Health & Family Welfare provides several vaccines to infants, children & pregnant women through UIP.
Immunization is a process through which a person is made immune to an infectious disease.
Polio is a viral disease that destroys the nerve cells present in the spinal cord causing paralysis or muscle weakness to some part of the body.
Pulse Polio Programme was launched in 1995 after a resolution for a global initiative of polio eradication was adopted by World Health Assembly (WHA) in 1988.
On 19 November 1985, GOI renamed EPI program, modifying the schedule as ‘Universal Immunization Program’ dedicated to the memory of Late Prime Minister Mrs Indira Gandhi.
UIP has two vital components: immunization of pregnant women against tetanus, and immunization of children
Universal Immunization Programme (UIP), started in India in 1985.
Ministry of Health & Family Welfare provides several vaccines to infants, children & pregnant women through UIP.
Immunization is a process through which a person is made immune to an infectious disease.
After the successful NSP 2017-2025,Goi is lauching NSP 2017-2025 for elimination of TB on 24th march( World TB day ) 2017. Module is on MOHFW site but i have try to keep it brief,hope its ll be useful specially for academic and administrative purposes.
- Video recording of this lecture in English language: https://youtu.be/lK81BzxMqdo
- Video recording of this lecture in Arabic language: https://youtu.be/Ve4P0COk9OI
- Link to download the book free: https://nephrotube.blogspot.com/p/nephrotube-nephrology-books.html
- Link to NephroTube website: www.NephroTube.com
- Link to NephroTube social media accounts: https://nephrotube.blogspot.com/p/join-nephrotube-on-social-media.html
Title: Sense of Smell
Presenter: Dr. Faiza, Assistant Professor of Physiology
Qualifications:
MBBS (Best Graduate, AIMC Lahore)
FCPS Physiology
ICMT, CHPE, DHPE (STMU)
MPH (GC University, Faisalabad)
MBA (Virtual University of Pakistan)
Learning Objectives:
Describe the primary categories of smells and the concept of odor blindness.
Explain the structure and location of the olfactory membrane and mucosa, including the types and roles of cells involved in olfaction.
Describe the pathway and mechanisms of olfactory signal transmission from the olfactory receptors to the brain.
Illustrate the biochemical cascade triggered by odorant binding to olfactory receptors, including the role of G-proteins and second messengers in generating an action potential.
Identify different types of olfactory disorders such as anosmia, hyposmia, hyperosmia, and dysosmia, including their potential causes.
Key Topics:
Olfactory Genes:
3% of the human genome accounts for olfactory genes.
400 genes for odorant receptors.
Olfactory Membrane:
Located in the superior part of the nasal cavity.
Medially: Folds downward along the superior septum.
Laterally: Folds over the superior turbinate and upper surface of the middle turbinate.
Total surface area: 5-10 square centimeters.
Olfactory Mucosa:
Olfactory Cells: Bipolar nerve cells derived from the CNS (100 million), with 4-25 olfactory cilia per cell.
Sustentacular Cells: Produce mucus and maintain ionic and molecular environment.
Basal Cells: Replace worn-out olfactory cells with an average lifespan of 1-2 months.
Bowman’s Gland: Secretes mucus.
Stimulation of Olfactory Cells:
Odorant dissolves in mucus and attaches to receptors on olfactory cilia.
Involves a cascade effect through G-proteins and second messengers, leading to depolarization and action potential generation in the olfactory nerve.
Quality of a Good Odorant:
Small (3-20 Carbon atoms), volatile, water-soluble, and lipid-soluble.
Facilitated by odorant-binding proteins in mucus.
Membrane Potential and Action Potential:
Resting membrane potential: -55mV.
Action potential frequency in the olfactory nerve increases with odorant strength.
Adaptation Towards the Sense of Smell:
Rapid adaptation within the first second, with further slow adaptation.
Psychological adaptation greater than receptor adaptation, involving feedback inhibition from the central nervous system.
Primary Sensations of Smell:
Camphoraceous, Musky, Floral, Pepperminty, Ethereal, Pungent, Putrid.
Odor Detection Threshold:
Examples: Hydrogen sulfide (0.0005 ppm), Methyl-mercaptan (0.002 ppm).
Some toxic substances are odorless at lethal concentrations.
Characteristics of Smell:
Odor blindness for single substances due to lack of appropriate receptor protein.
Behavioral and emotional influences of smell.
Transmission of Olfactory Signals:
From olfactory cells to glomeruli in the olfactory bulb, involving lateral inhibition.
Primitive, less old, and new olfactory systems with different path
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?bkling
Are you curious about what’s new in cervical cancer research or unsure what the findings mean? Join Dr. Emily Ko, a gynecologic oncologist at Penn Medicine, to learn about the latest updates from the Society of Gynecologic Oncology (SGO) 2024 Annual Meeting on Women’s Cancer. Dr. Ko will discuss what the research presented at the conference means for you and answer your questions about the new developments.
Couples presenting to the infertility clinic- Do they really have infertility...Sujoy Dasgupta
Dr Sujoy Dasgupta presented the study on "Couples presenting to the infertility clinic- Do they really have infertility? – The unexplored stories of non-consummation" in the 13th Congress of the Asia Pacific Initiative on Reproduction (ASPIRE 2024) at Manila on 24 May, 2024.
Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...VarunMahajani
Disruption of blood supply to lung alveoli due to blockage of one or more pulmonary blood vessels is called as Pulmonary thromboembolism. In this presentation we will discuss its causes, types and its management in depth.
Prix Galien International 2024 Forum ProgramLevi Shapiro
June 20, 2024, Prix Galien International and Jerusalem Ethics Forum in ROME. Detailed agenda including panels:
- ADVANCES IN CARDIOLOGY: A NEW PARADIGM IS COMING
- WOMEN’S HEALTH: FERTILITY PRESERVATION
- WHAT’S NEW IN THE TREATMENT OF INFECTIOUS,
ONCOLOGICAL AND INFLAMMATORY SKIN DISEASES?
- ARTIFICIAL INTELLIGENCE AND ETHICS
- GENE THERAPY
- BEYOND BORDERS: GLOBAL INITIATIVES FOR DEMOCRATIZING LIFE SCIENCE TECHNOLOGIES AND PROMOTING ACCESS TO HEALTHCARE
- ETHICAL CHALLENGES IN LIFE SCIENCES
- Prix Galien International Awards Ceremony
These simplified slides by Dr. Sidra Arshad present an overview of the non-respiratory functions of the respiratory tract.
Learning objectives:
1. Enlist the non-respiratory functions of the respiratory tract
2. Briefly explain how these functions are carried out
3. Discuss the significance of dead space
4. Differentiate between minute ventilation and alveolar ventilation
5. Describe the cough and sneeze reflexes
Study Resources:
1. Chapter 39, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 34, Ganong’s Review of Medical Physiology, 26th edition
3. Chapter 17, Human Physiology by Lauralee Sherwood, 9th edition
4. Non-respiratory functions of the lungs https://academic.oup.com/bjaed/article/13/3/98/278874
Anti ulcer drugs and their Advance pharmacology ||
Anti-ulcer drugs are medications used to prevent and treat ulcers in the stomach and upper part of the small intestine (duodenal ulcers). These ulcers are often caused by an imbalance between stomach acid and the mucosal lining, which protects the stomach lining.
||Scope: Overview of various classes of anti-ulcer drugs, their mechanisms of action, indications, side effects, and clinical considerations.
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdfAnujkumaranit
Artificial intelligence (AI) refers to the simulation of human intelligence processes by machines, especially computer systems. It encompasses tasks such as learning, reasoning, problem-solving, perception, and language understanding. AI technologies are revolutionizing various fields, from healthcare to finance, by enabling machines to perform tasks that typically require human intelligence.
2. What is DOTS?
DOTS is a comprehensive strategy recommended by
WHO for the detection and cure of tuberculosis.
A trained health care worker or a designated
individual provides the prescribed anti-tuberculous
drugs and watches the patient swallow every dose.1
3. PROCEDURE:
Patients with infectious tuberculosis are:
Identified using microscopy services.
Health workers then observe and record patients
swallowing the full course of the correct dosage of
anti-TB medicines for 6 to 8months.
Sputum smear testing is repeated after two months,
to check progress, and at the end of treatment.
A recording and reporting system documents
patients' progress throughout, and the final outcome
of treatment.
4. HISTORY OF DOTS:
During World War II : Styblo at 24 years of age, contracts
tuberculosis at a concentration camp.
1980: Styblo defines IUATLD model to control TB in
Tanzania2
1990: World Bank asks Styblo to create Pilot project for
China
1993: WHO declares TB as a global emergency
1994: New TB control framework [Dr Arata Kochi]
1995: DOTS launched as a WHO strategy
6. The five components of DOTS4:
1. Effective political and administrative commitment.
2. Case finding primarily by microscopic examination
of sputum of patients presenting to health
facilities.
3. Short-course chemotherapy given under direct
observation.
4. An effective drug supply and management
system.
5. Systematic monitoring and evaluation system.
7. 1. Effective political and
administrative commitment.
Sustained political commitment at all levels with
provision of adequate and competent resources
required for the program including infrastructure as
well as manpower.
Local partnership and commitment.
Provision of adequate funding.
Recognition of TB as a public health responsibility
and priority.
8. 2. Case detection through quality-
assured bacteriology
Bacteriology remains the recommended method of
TB case detection, first using sputum smear
microscopy and then culture and drug susceptibility
testing.
Adequate provision of high quality diagnostic
laboratories, microscopes, lab workers and reporting
facilities.
9. 3. Short-course chemotherapy given
under direct observation.
Provision of standardized treatment according to
WHO which includes a 6 or 8 months
regimen(2HRZE/4HR)5
Provision of treatment under supervision of a health
worker or designated individual.
10. 4. An effective drug supply and
management system
An uninterrupted and sustained supply of quality
assured anti-TB drugs free of cost is fundamental to
TB control.
Legislation related to drug regulation should be in
place, and use of anti-TB drugs by all providers
should be strictly monitored
11. 5. Monitoring and evaluation system
Maintaining a standardized recording of individual
patient data, which can be used at the facility level to
monitor treatment outcomes, to identify local problems
as they arise, and to evaluate the performance of each
country.
12. DOTS IN PAKISTAN:
Pakistan ranks 8th amongst the top 22 TB burden
countries in the world. According to estimates about
300,000 new cases are added each year with Punjab
having a quarter of the total disease burden.6
DOTS program was started in Pakistan in 1995, under
the National TB Control Program however the non-
availability of funds from regular health budget brought it
to a halt.
In 2000, it was revived and funds were allocated to it
seeking to provide 100% TB care to its population by
2005.
By 2005, DOTS had been set up all over Pakistan.
13. TARGET:
Increase cure rates to 85% and above.
Increase case detection to 70%.
100% DOTS coverage by 2005.
Reduce mortality and morbidity from TB by 50% by
the year 2010.
To achieve Millennium Development Goals by
2015.
14. ACHIEVEMENTS:
DOTS coverage in Pakistan achieved in May 2005
Achievement of TB related MDG Targets by 2008
DOTS expansion to 36 districts of Punjab.
Capacity building of districts; Training of doctors and
paramedics, at all levels healthcare.
Expansion of laboratories network.
Advocacy, communication and social mobilization:
media, news letter, billboards.
Engaging all care providers: Private as well as
public.
16. CHALLENGES:
Financial constraints.
Emergence of MDR-TB and HIV.
Capacity building constraints.
Inadequate laboratory services.
Inadequate information systems.
Unaccounted migration from high prevalence areas
with inadequate DOTS coverage.
17. Why DOTS?
To ensure adherence to treatment regimen.
To check for side effects if any.
To decrease the risk of drug resistance caused by
incomplete treatment.
To enforce standard protocol for the detection and
treatment of tuberculosis as recommended by
WHO.
For maintenance of proper recording and
monitoring system.
Diagnosis is simple, and treatment cures over 95%
of patients in clinical trials.
19. The Stop TB Strategy:
WHO developed a new six point Stop TB Strategy in
2000 which builds on the success of DOTS while also
explicitly addressing the key challenges facing TB.
Vision: A world free of TB.
Goal: To reduce dramatically the global burden of TB
by 2015 in line with the MDGs and the Stop TB
targets,to achieve major progress in the research and
development for tuberculosis cure.
To eliminate tb by 2050.
20. OBJECTIVES:
To achieve universal access to high
quality diagnosis and treatment for
people with TB.
To reduce the suffering and socio-
economic burden associated with TB.
To protect poor and vulnerable populations from
TB, TB/HIV and MDR-TB.
To support the development of new tools
and enable their timely and effective use.
21. COMPONENTS:
1. Pursue high-quality DOTS expansion and
enhancement.
2. Address TB/HIV, MDR-TB and other challenges.
3. Contribute to health system strengthening.
4. Engage all care providers.
5. Empower people against tuberculosis.
6. Enable and promote research.
22.
23. DOTS PLUS:
DOTS- Plus is a new strategy that is designed to manage
MDR-TB in resource limited countries.
Drug-resistant TB is caused by inconsistent, partial or
incorrect treatment of drug-susceptible TB.
MDR-TB is a specific form of drug resistant TB that is
resistant to at least Isoniazid and Rifampicin, the two most
powerful first-line anti-TB drugs.
Treatment regimen includes the use of 2nd line anti-TB
drugs that are expensive and required to be taken for a
longer time with greater side effects.